top of page

Sunday 7th December

Challanges & perspectives
in Nephrology

3WSHT_edited.jpg

Hands-on training

CH25-PRAKTIKH_2_edited.jpg

Coffee-1

10:00

Hands-on training

CH25-PRAKTIKH_2_edited.jpg

N.1. Παρακέντηση φίστουλας με υπερηχογραφική καθοδήγηση

Quality of Care and patient safety

Q&S_edited.jpg

C.1. Quality of Care and patient safety: principles

  1. The role of standards and patient safety indicators         

  2. The role of the Renal registries  

  3. The importance of staff training, competence and                  revalidation​

  4. HASIN accreditation

C.2. Quality of Care and patient safety: policies

  1. The CQC standards and policies for Dialysis Units

  2. The UKKA KQI Program   

  3. The Greek national policy

  4. Empowering patients to get their voice heard​

Coffee-2

13:00

Workshop on home therapies

3WSHTs-FINAL_edited.jpg

S.3. Healthcare systems & policies

  1. Achieving equity in dialysis care and outcomes:

      the role of policies

  2. System-Level Strategies to Improve Home Dialysis

S.4. Quality of life

  1. Patient reported experience and outcome measures

  2. Burden of treatment, social engagement and

      employment across different modalities

S.5. Clinical outcomes

  1.Cardiovascular outcomes across different modalities

  2. The role of networks and the interdisciplinary team

K.2. e-Poster session

General assembly & elections

Lunch

14:00

S.7. Nursing session

  1. Haemodialysis protocols

  2. EDTNA accreditation of nursing training

  3. Dry weight assessment

Hands-on training

CH25-PRAKTIKH_2_edited.jpg

K.2. e-Poster session

Έκθεση εξοπλισμού

κατ' οίκον κάθαρσης

Coffee-3

17:00

Κ.4. Cardio-renal-metabolic syndrome

  1. SGLT2 inhibitors: update  
  2. The place of GLP-1 agonists in clinical practice

  3. The place of MRAs in clinical practice

Κ.8. Hypertension

  1. Guidelines on hypertension in CKD patients 

  2. Clinical trial update on hypertension

Κ.5. Cardiovascular morbidity in CKD 

  1. Treatment on hyperlipidaemia: what's new?

  2. Challenges in the treatment of heart failure

Κ.3. What's new in heamodialysis?

  1. Uraemic pruritus: systemic screening and assessment in view of the novel therapies

  2. IDPN: when, to whom, and how?

  3. HIF inhibitors: their place in clinical practice

  4. Treatment of hyperparathyroidism

​​K.6. Hereditary nephropathies

1. ADPKD: The importance of the total kidney volume          (TKV) - new data and applications

2. Fabry disease: what should I know?

Κ.7. Clinical Nephrology

  1. Novel & emerging treatments in IgA nephropathy

  2. How to treat the patient with IgA nephropathy?

Λήξη

bottom of page